This inventor holds 2 USPTO granted patents. Top assignees: Carl Zeiss Meditec Ag, Carl Zeiss Surgical Gmbh. Active years: 2011-2015.
Company Filing History:
Years Active: 2011-2015
Title: The Innovations of Stefan Graeber
Introduction
Stefan Graeber is a notable inventor based in Munich, Germany. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, Graeber's work focuses on enhancing the precision of eye examinations and surgical procedures.
Latest Patents
One of his latest patents is an ophthalmologic visualization system. This method determines the position and/or radius of the limbus and/or the position and/or radius of the pupil of a patient's eye. The process involves obtaining an image of the patient's eye and correlating it with a plurality of different ring-shaped comparison objects. These objects have respective radii and centers, allowing for a local best match between the image and the comparison objects. The method identifies the position of the center of the comparison object that best matches the image, thereby determining the center of the limbus and/or the pupil.
Another significant patent is a computer-generated interface for a touch-sensitive computer screen. This innovation aims to improve user interaction with medical devices, making them more intuitive and efficient.
Career Highlights
Stefan Graeber has worked with prominent companies in the medical technology sector, including Carl Zeiss Meditec AG and Carl Zeiss Surgical GmbH. His experience in these organizations has allowed him to develop cutting-edge technologies that enhance the capabilities of ophthalmic devices.
Collaborations
Throughout his career, Graeber has collaborated with talented professionals, including Keith Thornton and Guenter Meckes. These partnerships have contributed to the advancement of his inventions and the overall progress in the field of ophthalmology.
Conclusion
Stefan Graeber's contributions to ophthalmology through his innovative patents demonstrate his commitment to improving eye care technology. His work continues to influence the industry and enhance patient outcomes.

